Graham Capital Management, L.P. Reata Pharmaceuticals Inc Transaction History

Graham Capital Management, L.P.

  • $4.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$22.15 - $42.11 $6.49 Million - $12.3 Million
-293,095 Reduced 92.53%
23,674 $899,000
Q3 2022

Nov 14, 2022
BUY
$19.41 - $36.49 $4.28 Million - $8.06 Million
220,748 Added 229.9%
316,769 $7.96 Million
Q2 2022

Aug 15, 2022
BUY
$20.71 - $36.5 $660,317 - $1.16 Million
31,884 Added 49.71%
96,021 $2.92 Million
Q1 2022

May 16, 2022
BUY
$24.12 - $39.6 $1.55 Million - $2.54 Million
64,137 New
64,137 $2.1 Million

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email